Experience with amikacin and colistin in an outbreak of infection by resistant Klebsiella aerogenes.
D000368:Aged; D000583:Amikacin / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D003091:Colistin / Q000627:therapeutic use*; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology; D004196:Disease Outbreaks; D004334:Drug Administration Schedule; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007612:Kanamycin / Q000031:analogs & derivatives*; D007710:Klebsiella Infections / Q000188:drug therapy* / Q000382:microbiology; D007711:Klebsiella pneumoniae / Q000187:drug effects / Q000302:isolation & purification; D008297:Male; D008875:Middle Aged; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000382:microbiology
D007612:Kanamycin; D000583:Amikacin; D003091:Colistin